Introduction
Whatever their circumstances of occurrence (accidental smoke inhalation in fires of various origin, occupational exposure, rare suicides by ingestion of cyanide salts, etc.), cyanide (CN) poisonings are always of forensic relevance and, therefore, necessitate highly reliable analytical tools. Among the wide range of methodologies proposed for the determination of CN in biological specimens, older colorimetric and spectrophotometric techniques (usually preceded by a microdiffusion or distillation step) still remain useful, especially for screening purposes in clinical situations (1, 2) . More recently, several separation procedures have become available, and they have substantially improved both the sensitivity and specificity of this analysis. Most of them involve headspace gas chromatography (HS-GC) with electron capture (3, 4) , nitrogen-phosphorus (5--7), or mass spectrometric detection (8) (9) (10) .
Alternatively, liquid chromatography has seldom been reported for CN determination, except for a few methods involving fluorometric detection after complexation of the analyte by the pyridine/barbiturate reaction (K~nig reaction) (11) or by naphthalene-2,3-dicarboxaldehyde in the presence of taurine (12) (13) (14) . This paper presents an original procedure, inspired by these latter works, that allows an unequivocal and accurate determination of CN in whole blood by means of high-performance liquid chromatography with mass spectrometric detection (HPLC-MS).
Experimental

Materials
Potassium cyanide (KCN, molecular weight [MW] = 65.1), potassium cyanide-13C-lSN (K13ClSN, MW = 67.1), naphthalene-2,3-dicarboxaldehyde (NDA, MW = 184.2), and taurine (MW = 125.2) were obtained from Sigma-Aldrich (Saint-QuentinFallavier, France). Methanol (MeOH) and acetonitrile were HPLC grade (Merck, Darmstadt, Germany). Concentrated (99-100%) formic acid (HCOOH) was Normatom grade (Prolabo, Paris, France). All other chemicals and reagents were analytical grade and purchased from Merck (Germany), Prolabo, and Fluka (Saint-Quentin-Fallavier, France).
Stock solutions of CN and the internal standard (IS) were prepared with KCN and KI3CISN at 10mM in 100mM sodium hydroxide, and working solutions were prepared just before use by appropriate dilutions in deionized water. A stock solution of NDA was prepared at 10mM in MeOH then stored at + 4~ in the dark, where it was found to be stable for at least 1 month. Taurine was prepared as a 50raM solution in deionized water, then stored under the same conditions. Working solutions of the derivatization reagent were prepared just before use by blending aliquots of these NDA and taurine solutions with MeOH and concentrated (approximately 20%) ammonia solution (NDNtaurinelMeOH/ammonia, 25:25:45:5, v/v). The pH 3.0 buffer was prepared using a 2mM NH4COOH solution (126.2 pg/mL) adjusted to the desired pH by the appropriate addition of concentrated HCOOH.
CN-free blood samples needed for recovery, limit of detection (LOD), and repeatability experiments were obtained by storing whole human blood (from the autopsy room or discarded from transfusion centers) for 48 h at room temperature in open vials. As checked by a routine HS-GC-MS procedure (10), the levels of CN in these blood samples were always < 10 ng/mL. Fortified blood was prepared just before analysis (because of the poor stability of CN in biological specimens) by spiking these samples with appropriate amounts of the KCN stock solution.
Instrumentation
The HPLC-MS system consisted of a 20-mL dual-syringe HPLC pump (Applied Biosystems 140B, Foster City, CA) and a Rheodyne 8125 manual injection valve connected via a pneumatically assisted electrospray interface (Ionspray TM, PerkinElmer Sciex, Foster City, CA) to a PerkinElmer Sciex API-100 single-quadrupole mass analyzer. Nitrogen (purity 99.95%, IAAir Liquide, Paris, France) at a pressure of 40 psi was employed both as the nebulizing gas (flow rate 1.16 L/min) and the 'curtain gas' (flow rate 1.08 L/rain), which flushes the ion sampling orifice (OR) of the vacuum chamber. The detector was operated in the negative ionization mode with voltages of -4.5 kV and -50 V, respectively, applied to the sprayer and OR, whereas the electron multiplier was set at + 2. Eppendorf-type plastic microtube was then inserted into this vial (to serve as the inner chamber of the microdiffusion system) and filled with 40 pL of the derivatization reagent (NDA/taurine/ MeOH/ammonia, 25:25:45:5, v/v). Concentrated sulfuric acid (2 mL) was added to the blood sample by dripping it carefully along the inner wall of the glass dish, and the headspace vial was then immediately sealed using a Teflon-lined aluminium cap. After 30 min of gentle, periodic agitation at ambient temperature, the cap was removed, and 2 pL of the contents of the inner vial was pipetted and directly injected onto the HPLC column at the beginning of each chromatographic run.
Results and Discussion
Naphthalene-2,3-dicarboxaldehyde (NDA) is a nonfluorescent, aromatic dialdehyde structurally related to o-phthalaldehyde (OPA), which specifically reacts with primary amines in the presence of excess cyanide to yield highly fluorescent N-substituted 1-cyano [/] benzoisoindole (CBI) derivatives (15) (16) (17) (18) (Figure 1 ). In addition, these NDA derivatives have been shown to be substantially more stable than the corresponding OPA derivatives with a stability lasting at least 24 h in chemical solutions (18) (19) (20) (21) . HPLC with pre-or postcolumn derivatization involving this NDA/CN reaction has been used since the late 1980s to assay biological samples for compounds bearing primary amine groups, including various amino acids (18, (22) (23) (24) , peptides (25) (26) (27) (28) , catecholamines (21) , or other drugs of pharmaceutical interest (29) . Subsequently, modified protocols that use an excess of an amine and limiting amounts of other nucleophiles have been developed for the detection of cyanide in blood, urine, and other biological specimens, either by direct spectrofluorometry on the derivatized samples (30) or by HPLC (12) (13) (14) . The latter methods involve dilution of the biological fluids by water + methanol, precolumn derivatization with NDA and taurine, followed by reversed-phase HPLC with fluorometric detection.
As tested in our laboratory, however, these procedures did not prove fully satisfactory and showed poor repeatability of the CN extraction yields, especially when applied to forensic samples (e.g., postmortem blood at various stages of putrefaction); this was probably due to matrix effects that have been shown to strongly affect the kinetics and efficiency of the NDA/CN reaction (31) . The lack of an appropriate internal standard also hampered the repeatability and accuracy of CN analysis by these methods. Figure 2 shows the full-scan (m/z 70-320), background-subtracted ionspray mass spectra of the CBI derivatives formed with CN and 13C15N.
This was recorded from a continuous, 5-1JL/min syringe infusion of extracts obtained from blood samples loaded at 100 IJg/mL with CN and ]3CISN. The representative spectrum of CN-spiked blood is relatively simple, showing a base peak at m/z 299 corresponding to the pseudomolecular anion [M-H]-. A unique fragment of close abundance, presumably due to loss of the ethanesulfonic group, is observed at m/z 191 and may be used as confirmation ion. As expected, the spectrum obtained from the 13ClSN-spiked blood exhibited quite similar features with a shift of +2 mass units in comparison with the former.
Under the described analytical conditions, the average retention times of both CBI derivatives in the chromatographic system were 4.69 min. Because of the preliminary microdiffusion step, SIM or TIC chromatograms were always of great purity, even when recorded from complex biological matrices or badly degraded samples (e.g., tissue homogenates or putrefied blood). The negative ionization mode employed for MS detection also contributes to the quality of chromatograms because only compounds containing electronegative groups will be ionized, with the consequence of a dramatic reduction in the Ievel of background noise in comparison with posiLive ion analyses. No interferences were observed from taurine and NDA remaining in excess in the extraction medium, that is, not consumed by the derivatization process. Even at high concentrations, NDA cannot be ionized under negative-ion conditions; on the other hand, taurine ionizes well and produces a typical spectrum with a base peak [M-H]-at m/z 124 (another peak of much lower abundance at m/z 249 probably results from a dimerization of taurine in the ionization source); however, this compound is not retained on the C18 column and co-elutes with the solvent front at the beginning of the chromatogram.
Using an isotopic analogue of CN for internal standardization had never been reported before, except for one single and relatively old work in which ClSN was employed for the quantitation of CN by GC-MS (32) . The recently available 13C15N salts, however, appear more satisfactory for this purpose because a gap of two mass units against the analyte is probably less prone to mass interferences. In our method, CN was quantitated by computing peak-height ratios (m/z 191/m/z 193 or m/z 299/m/z 301) from the CBI derivatives of CN and 13C15N and by plotting the resulting values against the calibration curve. In practice, this operation was quite simple because the blood samples were spiked with 13C15N at a resulting concentration of i pg/mL. Thus, the CN concentration in micrograms per milliliter was directly given by the ratio of peak heights (CN/13C15N). In both accuracy and elegance, this method represents a significant improvement over the standard addition technique or other kinds of external standardization (e.g., with acetonitrile) generally employed in chromatographic procedures devoted to CN analysis.
Absolute recovery was determined by extracting and assaying CN-free blood samples fortified to contain 100 and 500 ng/mL CN and by (:omparing the representative peak heights of the CBI derivatives in SIM mode (m/z 299) with those obtained by pouring directly equivalent loads of the KCN stock solution into the inner well of the microdiffusion device (the outer well being kept empty). Results (mean + S.D. of six replicates at each concentration) were 88.0 • 5.7% and 85.7 + 6.6%. These recoveries were found satisfactory, and quite similar to those obtained for equivalent diffusion times with conventional, reusable Conway cells (2) . This confirms that equilibration times formerly recommended with microdiffusion devices (2-3 h) may be substantially shortened without affecting the performances of the assay; in our study, experiments done with decreasing times allowed to the diffusion step showed no significant differences (in terms of CN recovery) over the range of 2 h to 30 rain. Moreover, acceptable recoveries (> 50%) were observed for diffusion times as low as 5 min; however, the reproducibility of results was poor. Finally, a 30-rain equilibration time was chosen as the best compromise for the assay. Within-run accuracy and precision, determined by extracting and assaying aliquots of CN-free blood fortified with CN at 500 ng/mL, were 2.3 and 7.4%, respectively (from six replicates). The day-to-day accuracy and precision were also determined at 500 ng/mL over a period of 10 days; the fortified blood samples were prepared daily and the HPLC-MS system was completely switched off overnight. Results were 2.7 and 8.9%, respectively. The lower LOD, which was determined by extracting and assaying CN-free blood samples spiked with CN at decreasing concentrations until a signal equivalent to 3 times the background noise was observed for the CBI derivative in SIM mode, was 5 ng/mL. The limit of quantitation (LOQ) was fixed at 15 ng/mL, and the method was found to be linear over the range 15-3000 ng/mL. Alternative procedures (especia]ly HPLC-fluorimetry after derivatization by NDA+taurine, or HS-GC-MS) have been claimed to provide better LODs in the range 0.2 to 5.0 ng/mL (6, (8) (9) (10) (11) 13, 14) , allowing physiological levels of CN in blood, plasma, or other matrices to be easily quantitated. CN toxicity is usually associated with blood concentrations > 500 ng/mL (33) ; the level of sensitivity of our technique, however, appears quite sufficient to permit valuable measurements in persons suspected of CN poisoning in clinical and forensic situations. As an example, Figure 3 presents the SIM chromatogram (m/z 191+193+299+301) recorded from the postmortem blood of a 32-year-old female, who was found comatose after prolonged exposure to the fumes of a household fire and died soon after admission to the ICU. Blood CN was 560 ng/mL (carboxyhemoglobin 42.7%).
In conclusion, the present method constitutes the first HPLC-MS procedure described for the detection of CN in human blood. Because of the combination of the microdiffusion and derivatization stages in a single step, sample preparation is particularly simple and rapid: the complete analytical process may be achieved in less than 45 min after receiving the blood sample of an intoxicated person. The use of 13C15N as internal standard, also reported for the first time in this paper, allows the quantitation of CN with elegance and accuracy in comparison with existing procedures. Finally, the selectivity of both the derivatization reaction and the MS detection make this method extremely specific and suitable for medicolegal as welt as clinical applications.
